中国生化药物杂志
中國生化藥物雜誌
중국생화약물잡지
CHINESE JOURNAL OF BIOCHEMICAL PHARMACEUTICS
2010年
1期
19-22
,共4页
马丽%蔡在龙%王庆蓉%雷呈祥
馬麗%蔡在龍%王慶蓉%雷呈祥
마려%채재룡%왕경용%뢰정상
Citroatatin%融合肤%抗肿瘤药%血管生成抑制
Citroatatin%融閤膚%抗腫瘤藥%血管生成抑製
Citroatatin%융합부%항종류약%혈관생성억제
citrostatin%fused peptide%antineoplastic drugs%antiangiogenesis
目的 构建重组靶向抗肿瘤肽(Citrostatin),研究其生物学活性.方法 构建Citrostatin重组基因,经原核生物表达和纯化获得Citrostatin融合蛋白,通过内皮细胞杀伤实验、细胞毒活性实验、体外管状机构生成抑制实验等分析Citrostatin的生物学活性.结果 Citrostatin融合蛋白经表达、酶切纯化后,目的蛋白纯度达90%以上.Citrostatin 能明显抑制内皮细胞ECV304的增殖(IC_(50)=2.28μmol/L),有效杀伤肿瘤细胞1990及NCI-H640(IC_(50)分别为9.24,2.7μmol/L),并明显抑制体外管状结构的生成.结论 成功构建了重组靶向抗肿瘤肽Citrostatin,细胞和血管水平研究表明该融合肽同时具有抑制肿瘤新生血管的形成和直接杀伤肿瘤的双重活性.
目的 構建重組靶嚮抗腫瘤肽(Citrostatin),研究其生物學活性.方法 構建Citrostatin重組基因,經原覈生物錶達和純化穫得Citrostatin融閤蛋白,通過內皮細胞殺傷實驗、細胞毒活性實驗、體外管狀機構生成抑製實驗等分析Citrostatin的生物學活性.結果 Citrostatin融閤蛋白經錶達、酶切純化後,目的蛋白純度達90%以上.Citrostatin 能明顯抑製內皮細胞ECV304的增殖(IC_(50)=2.28μmol/L),有效殺傷腫瘤細胞1990及NCI-H640(IC_(50)分彆為9.24,2.7μmol/L),併明顯抑製體外管狀結構的生成.結論 成功構建瞭重組靶嚮抗腫瘤肽Citrostatin,細胞和血管水平研究錶明該融閤肽同時具有抑製腫瘤新生血管的形成和直接殺傷腫瘤的雙重活性.
목적 구건중조파향항종류태(Citrostatin),연구기생물학활성.방법 구건Citrostatin중조기인,경원핵생물표체화순화획득Citrostatin융합단백,통과내피세포살상실험、세포독활성실험、체외관상궤구생성억제실험등분석Citrostatin적생물학활성.결과 Citrostatin융합단백경표체、매절순화후,목적단백순도체90%이상.Citrostatin 능명현억제내피세포ECV304적증식(IC_(50)=2.28μmol/L),유효살상종류세포1990급NCI-H640(IC_(50)분별위9.24,2.7μmol/L),병명현억제체외관상결구적생성.결론 성공구건료중조파향항종류태Citrostatin,세포화혈관수평연구표명해융합태동시구유억제종류신생혈관적형성화직접살상종류적쌍중활성.
Purpose To construct a recombined antitumor peptide and to analyze its bioactivity. Methods Constructing a recombined gene and inserting the pGEX-4T-3 vector. The recombined protein was expressed in E. coli BL21 and purified with Amylose Resin. Then, citrostatin was subjected to the following tests separately: inhibition of endothelial cell proliferation, MTT test of cytotoxicity and inhibition of endothelial cell tube formation on ECMatrix. Results Citrostatin significantly inhibited the proliferation of human endothelial cell ECV304(IC_(50) = 2.28 μmol/L) .It also significantly inhibited the proliferation of human tumor cell 1990 and NCI-H64O(IC_(50) = 9.24,2.74 μmol/L) ,and the inhibitory effect became more marked with the increase of citrostatin concentration. The inhibitory effects of citrostatin on endothelial cell tube formation was also confirmed . Conclusion An antitumor peptide, citrostatin, has been successfully constructed and purified, which showed anti-angiogenesis effect and direct cytotoxic effect on tumor cells.